These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14558332)

  • 21. [Usefulness of osteocalcin and CrossLaps as markers of bone turnover in children with chronic renal failure].
    Polak-Jonkisz D; Zwolińska D; Bednorz R; Owczarek H; Nahaczewska W
    Pol Merkur Lekarski; 2002 Apr; 12(70):257-60. PubMed ID: 12089882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTH 1-84 and PTH "7-84" in the noninvasive diagnosis of renal bone disease.
    Coen G; Bonucci E; Ballanti P; Balducci A; Calabria S; Nicolai GA; Fischer MS; Lifrieri F; Manni M; Morosetti M; Moscaritolo E; Sardella D
    Am J Kidney Dis; 2002 Aug; 40(2):348-54. PubMed ID: 12148108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variable parathyroid hormone(1-84)/carboxylterminal PTH ratios detected by 4 novel parathyroid hormone assays.
    Koller H; Zitt E; Staudacher G; Neyer U; Mayer G; Rosenkranz AR
    Clin Nephrol; 2004 May; 61(5):337-43. PubMed ID: 15182128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum osteoprotegerin and renal osteodystrophy.
    Coen G; Ballanti P; Balducci A; Calabria S; Fischer MS; Jankovic L; Manni M; Morosetti M; Moscaritolo E; Sardella D; Bonucci E
    Nephrol Dial Transplant; 2002 Feb; 17(2):233-8. PubMed ID: 11812872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of whole PTH assay in patients with renal osteodystrophy--correlation with bone scintigraphy.
    Kaida H; Ishibashi M; Nishida H; Baba K; Hiromatsu Y; Okuda S; Hayabuchi N
    Ann Nucl Med; 2005 May; 19(3):179-84. PubMed ID: 15981669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous vitamin D therapy reduces PTH-(1-84)/large C fragments ratio in chronic hemodialysis patients.
    Kihara T; Ichikawa H; Morimoto H; Yano A; Akagi S; Nakao K; Kohmoto H; Wada J; Kumagai I; Makino H
    Nephron Clin Pract; 2004; 98(3):c93-100. PubMed ID: 15528944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Tartrate-resistant acid phosphatase--TRAP 5b--as a novel marker of bone resorption in patients with irreversible renal failure treated with dialysis].
    Nowak Z; Konieczna M; Wańkowicz Z
    Pol Merkur Lekarski; 2004 Aug; 17(98):138-41. PubMed ID: 15603322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
    Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
    Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients.
    Monier-Faugere MC; Geng Z; Mawad H; Friedler RM; Gao P; Cantor TL; Malluche HH
    Kidney Int; 2001 Oct; 60(4):1460-8. PubMed ID: 11576360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An evaluation of 1-84 PTH measurement in relation to bone alkaline phosphatase and bone Gla protein in hemodialysis patients.
    Miwa N; Nitta K; Kimata N; Watanabe Y; Suzuki K; Kawashima A; Haga M; Watanabe R; Aoki T; Akiba T; Nihei H
    Nephron Clin Pract; 2003; 94(2):c29-32. PubMed ID: 12845234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone histomorphometry of renal osteodystrophy in diabetic patients.
    Andress DL; Hercz G; Kopp JB; Endres DB; Norris KC; Coburn JW; Sherrard DJ
    J Bone Miner Res; 1987 Dec; 2(6):525-31. PubMed ID: 3455634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Intact whole bioactive parathormone: problems arising from comparing different methods].
    Marangella M; Migliardi M; Dutto F; Mengozzi G; Marranca D; Bagnis C; Berutti S; Gallone G; Aimo G; Ramello A; Fonzo D
    G Ital Nefrol; 2002; 19(4):467-75. PubMed ID: 12369051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy.
    Mazzaferro S; Pasquali M; Ballanti P; Bonucci E; Costantini S; Chicca S; De Meo S; Perruzza I; Sardella D; Taggi F
    Nephrol Dial Transplant; 1995; 10(1):52-8. PubMed ID: 7724029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. K/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients.
    Barreto FC; Barreto DV; Moysés RM; Neves KR; Canziani ME; Draibe SA; Jorgetti V; Carvalho AB
    Kidney Int; 2008 Mar; 73(6):771-7. PubMed ID: 18185506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
    Małyszko J; Małyszko JS; Pawlak K; Wołczyński S; Myśliwiec M
    Adv Med Sci; 2006; 51():69-72. PubMed ID: 17357281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Function of parathyroid glands in kidney transplant patients--diagnostic value of CAP and CIP.
    Spiechowicz U; Kokot F; Wiecek A
    Ann Transplant; 2004; 9(3):33-6. PubMed ID: 15759544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intact PTH combined with the PTH ratio for diagnosis of bone turnover in dialysis patients: a diagnostic test study.
    Herberth J; Branscum AJ; Mawad H; Cantor T; Monier-Faugere MC; Malluche HH
    Am J Kidney Dis; 2010 May; 55(5):897-906. PubMed ID: 20347512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New assays for parathyroid hormone (PTH) and the relevance of PTH fragments in renal failure.
    Goodman WG
    Kidney Int Suppl; 2003 Nov; (87):S120-4. PubMed ID: 14531784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoalbuminemia differently affects the serum bone turnover markers in hemodialysis patients.
    Zheng CM; Wu CC; Lu CL; Hou YC; Wu MS; Hsu YH; Chen R; Chang TJ; Shyu JF; Lin YF; Lu KC
    Int J Med Sci; 2019; 16(12):1583-1592. PubMed ID: 31839746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.